Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

172.98
Delayed Data
As of Jun 23
 -1.94 / -1.11%
Today’s Change
161.09
Today|||52-Week Range
209.22
+1.53%
Year-to-Date
Kamada Withdraws Inhaled AAT Marketing Application in EU
Jun 23 / Zacks.com - Paid Partner Content
Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
Jun 21 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
Jun 23 / Zacks.com - Paid Partner Content
Could Shire PLC (SHPG) Be a Great Stock for Value Investors?
Jun 19 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused
Jun 16 / Zacks.com - Paid Partner Content
Biotech Movers: Shire, Bellicum, Organovo
Jun 22 / TheStreet.com - Paid Partner Content